Could HIV drugs help slow Alzheimer's? new safety trial begins

NCT ID NCT07210528

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times

Summary

This study tests whether two HIV medications, emtricitabine and Descovy, are safe for people with mild cognitive impairment (MCI), a condition that often leads to Alzheimer's. Researchers think these drugs might slow memory decline by blocking a process linked to Alzheimer's. About 48 adults with MCI will take either the drug or a placebo daily for 3 months, with close monitoring for side effects and early signs of benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National University Hospital

    RECRUITING

    Singapore, Singapore

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.